72 / 100

Dr. Herman Perroud | Medicine and Dentistry | Best Researcher Award

Medical Oncology of Sanatorio de la mujer, Argentina

Dr. Herman Perroud is a distinguished MEDICAL ONCOLOGIST affiliated with SANATORIO DE LA MUJER, focusing on innovative research in BREAST CANCER and LUNG CANCER. His career is marked by leadership in the EARLY DETECTION PROGRAM OF LUNG CANCER in ROSARIO ARGENTINA and oversight of numerous clinical trials. With memberships in ASCO and ESMO, he contributes extensively to oncological advancements. Dr. Perroud’s contributions include publications in prominent journals, exploring new strategies like LOW DOSE CHEMOHERAPY for BREAST CANCER treatment. Recognized internationally for his scientific innovations, he continues to shape the field of oncology with dedication and expertise. 🌟🔬

Professional Profile:



Dr. Herman Perroud is a dedicated MEDICAL ONCOLOGIST at SANATORIO DE LA MUJER, focusing on BREAST CANCER and LUNG CANCER research. His academic endeavors include spearheading the EARLY DETECTION PROGRAM OF LUNG CANCER in ROSARIO ARGENTINA and contributing to clinical trials.


Professional Experience 📚


Dr. Herman Perroud, a distinguished Medical Oncologist affiliated with Sanatorio de la Mujer, brings extensive expertise in oncology and clinical research. With a robust career spanning years of dedicated service, he has contributed significantly to advancing cancer treatment methodologies, particularly in breast and lung cancers. Dr. Perroud leads multiple clinical trials, including an innovative Early Detection Program for Lung Cancer in Rosario, Argentina. His professional journey includes collaborations with international bodies like ASCO and ESMO, underscoring his commitment to global oncological advancements. Dr. Perroud’s impactful research, published in prestigious journals, focuses on early cancer detection and novel chemotherapy approaches for breast cancer treatment.

Research Interest 🔍

Dr. Herman Perroud’s research interests 🧬🔬 revolve around pioneering advancements in oncology, particularly focusing on breast and lung cancers. He is committed to exploring innovative methods for early cancer detection and refining therapeutic approaches, including low-dose chemotherapy. Dr. Perroud’s research aims to deepen the understanding of tumor biology and treatment modalities through rigorous clinical trials and collaborative studies. His work also encompasses investigating personalized medicine strategies and novel therapies to enhance treatment effectiveness and patient care in oncology.

Award and Honor🏆

Dr. Herman Perroud has received prestigious awards and honors in recognition of his contributions to medical oncology and research. His accolades underscore his dedication to advancing treatments for breast and lung cancers through innovative approaches. These awards highlight his significant impact on early detection methods for lung cancer in Rosario, Argentina, and his pioneering work in low-dose chemotherapy for breast cancer treatment. Dr. Perroud’s achievements are a testament to his leadership in the field, enhancing patient care and advancing scientific knowledge in oncology. 🏆🌟

Research Skills🌟

Dr. Herman Perroud is highly skilled in conducting cutting-edge research in the field of medical oncology, particularly focusing on breast cancer and lung cancer. His research skills encompass a wide range of methodologies, including clinical trials management and the implementation of innovative early detection programs. He demonstrates proficiency in data analysis, experimental design, and the application of advanced medical technologies to improve cancer diagnosis and treatment outcomes. Dr. Perroud’s contributions to the field reflect his deep commitment to advancing oncological research and translating scientific findings into impactful clinical practices, thereby significantly benefiting patients and the medical community alike.


  • Spearheaded the Early Detection Program of Lung Cancer in Rosario, Argentina.
  • Managed multiple clinical trials focusing on innovative treatments for breast cancer and lung cancer.
  • Published extensively in reputable journals on advancements in early cancer detection and low-dose chemotherapy.
  • Received international recognition and awards for contributions to oncological research.
  • Active member of prestigious organizations such as ASCO (American Society of Clinical Oncology) and ESMO (European Society for Medical Oncology).
  • Established collaborations with prominent researchers and institutions globally.
  • Contributed significantly to the development of new methodologies in cancer research and treatment.
  • Recognized for leadership in integrating research findings into clinical practice to enhance patient care and outcomes.


  • Book Chapter
    • Title: Protective effect of Vitamin A on male lung cancer
    • Authors: Dagatti, M.S., Compagnucci, A.B., Perroud, H.A., Pezzotto, S.M.
    • Book: Vitamin A: Nutrition, Side Effects and Supplements, 2021, pp. 193–210
  • Review Article
    • Title: Achievements and challenges in the use of metronomics for the treatment of breast cancer
    • Authors: Scharovsky, O.G., Rico, M.J., Mainetti, L.E., Perroud, H.A., Rozados, V.R.
    • Journal: Biochemical Pharmacology, 2020, 175, 113909
  • Article
    • Title: Correlation between predictors of coledocolithasis and findings of endoscopic retrograde cholangiopancreatography. From guidelines to practice | Correlación entre predictores de litiasis coledociana y los hallazgos en la colangiopancreatografía retrógrada endoscópica. De las guías a la práctica
    • Authors: Ripari, G., Wulfson, A., Guerrina, C., Perroud, H.
    • Journal: Acta Gastroenterologica Latinoamericana, 2017, 47(4), pp. 269–276
  • Article
    • Title: Putative Biomarkers of Response to Treatment in Breast Cancer Patients: A Pilot Assay
    • Authors: Rico, M.J., Perroud, H.A., Herrera, C., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Investigation, 2017, 35(6), pp. 377–385
  • Article
    • Title: The association between osteoporotic hip fractures and actinic lesions as a biomarker for cumulative sun exposure in older people—a retrospective case–control study in Argentina
    • Authors: Perroud, H.A., Dagatti, M.S., Amigot, B., Masoni, A.M., Pezzotto, S.M.
    • Journal: Journal of Bone and Mineral Metabolism, 2017, 35(3), pp. 324–329
  • Article
    • Title: Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
    • Authors: Perroud, H.A., Scharovsky, O.G., Rozados, V.R., Alasino, C.M.
    • Journal: ecancermedicalscience, 2017, 11, 723
  • Article
    • Title: A nested case-control study on dietary fat consumption and the risk for gallstone disease
    • Authors: Bertola Compagnucci, A., Perroud, H.A., Batallés, S.M., Berli, D., Pezzotto, S.M.
    • Journal: Journal of Human Nutrition and Dietetics, 2016, 29(3), pp. 338–344
  • Article
    • Title: Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy
    • Authors: Perroud, H.A., Alasino, C.M., Rico, M.J., Rozados, V.R., Scharovsky, O.G.
    • Journal: Future Oncology, 2016, 12(10), pp. 1233–1242
  • Article
    • Title: Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: Clinical outcomes and biomarkers of response
    • Authors: Perroud, H.A., Alasino, C.M., Rico, M.J., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Chemotherapy and Pharmacology, 2016, 77(2), pp. 365–374
  • Article
    • Title: Comparative effectiveness of two metronomic chemotherapy schedules-our experience in the preclinical field
    • Authors: Rico, M.J., Perroud, H.A., Mainetti, L.E., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Investigation, 2014, 32(3), pp. 92–98
Herman Perroud | Medicine and Dentistry | Best Researcher Award

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *